Studies have shown that epigenetic and transcriptional levels of TET2 are significantly upregulated in neurons of PD patients, leading to an abnormal increase in hydroxymethylation levels in the enhancer region, which may exacerbate disease progression by triggering aberrant neuronal function and immune‐inflammatory responses [106]. The gene discussed is TET2; the disease is Parkinson disease.